Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

IASLC Announces New JTO CRR Editor-in-Chief

… Dr. Emily Stone will succeed JTO Clinical and Research Reports founding editor Dr. Alex A. Adjei, who will …

In Case You Missed It: Recent News from IASLC

Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients

… Feldman said ensuring the patient voice is present in research helps to improve the work being done to reduce the …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …

IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology

… Tuesday morning, nine expert clinicians and researchers in the field will give award lectures in honor of …

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

Patient Advocate Ivy B. Elkins Leaves Lasting Legacy

… her warm and energetic approach to furthering lung cancer research efforts. … Patient Advocate Ivy B. Elkins Leaves …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …